Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Digihaler refers to a family of prescription digital inhalers equipped with built-in electronic modules that detect, record, and store data on inhaler use for transmission to a mobile app. The main products under the "Digihaler" brand are: - **ProAir Digihaler** (albuterol sulfate): A quick-relief (rescue) dry powder inhaler containing albuterol sulfate, a short-acting beta2-adrenergic agonist. It is indicated for the treatment or prevention of bronchospasm in patients with reversible obstructive airway disease and for prevention of exercise-induced bronchospasm[1][4][6]. - **AirDuo Digihaler** (fluticasone propionate and salmeterol): A combination dry powder inhaler containing fluticasone propionate (an inhaled corticosteroid) and salmeterol (a long-acting beta2-adrenergic agonist). It is indicated for maintenance treatment of asthma in patients aged 12 years and older[3][5][7]. - **ArmonAir Digihaler** (fluticasone propionate): An inhaled corticosteroid-only product used as long-term maintenance therapy for asthma in patients 12 years and older[2][8]. All these products feature digital connectivity to help track medication usage but differ by active ingredients and clinical indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Digihaler.